Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28868 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Valentina Mazzotta und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Research Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Mpox, Monkeypox. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Tecovirimat is a treatment option for severe mpox, although randomized clinical trials are ongoing. The aim of the study is to assess the effect of tecovirimat on healing time and the extent of viral clearance by target trial emulation using observational data. Clinical and virological data of patients hospitalized for mpox were collected. Samples from the upper respiratory tract (URT) were grouped in two time points: T1 (median 6 days from symptoms onset) and T2 (median 5 days from T1). Patients were followed‐up until recovery. Average treatment effect (ATE) in patients untreated versus treated with tecovirimat was estimated on time to healing and variation in viral load in URT, using a weighted and cloning analysis. Among the 41 patients included, 19 completed a course of tecovirimat. The median time from symptoms onset to hospitalization and to drug‐starting was 4 days and 10 days, respectively. No improvement in healing time in treated versus untreated was observed. No difference by treatment group in time to viral clearance was detected by ATE fitted in a subset of 13 patients after controlling for confounders. We found no evidence for a large effect of tecovirimat in shortening healing time and viral clearance. While awaiting the results of randomized studies, the use of tecovirimat should be restricted to the clinical trial setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Research Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
- Doctoral School of Microbiology, Immunology, Infectious Diseases, and Transplants (MIMIT), University of Rome Tor Vergata, Rome, Italy.
- Centre for Clinical Research, Epidemiology, Modelling, and Evaluation (CREME), Institute for Global Health, UCL, London, UK.
- Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
- Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy.
- Pharmacy Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
ORCID-Profile: Valentina Mazzotta, Annalisa Mondi
Förderung
- Ministero della Salute
Zitieren
APA
Mazzotta, V., Cozzi-Lepri, A., Lanini, S., Mondi, A., Carletti, F., Tavelli, A., Gagliardini, R., Vita, S., Pinnetti, C., Aguglia, C., Colavita, F., Faccendini, P., Matusali, G., Faraglia, F., Beccacece, A., Paulicelli, J., Girardi, E., Nicastri, E., Vaia, F., …, & Antinori, A. (2023). Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox. Journal of Medical Virology. https://doi.org/10.1002/jmv.28868
Vancouver
Mazzotta V, Cozzi-Lepri A, Lanini S, Mondi A, Carletti F, Tavelli A, et al. Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox. Journal of Medical Virology. 2023. doi:10.1002/jmv.28868
BibTeX
@article{Mazzotta2023,
author = {Mazzotta, Valentina and Cozzi-Lepri, Alessandro and Lanini, Simone and Mondi, Annalisa and Carletti, Fabrizio and Tavelli, Alessandro and Gagliardini, Roberta and Vita, Serena and Pinnetti, Carmela and Aguglia, Camilla and Colavita, Francesca and Faccendini, Paolo and Matusali, Giulia and Faraglia, Francesca and Beccacece, Alessia and Paulicelli, Jessica and Girardi, Enrico and Nicastri, Emanuele and Vaia, Francesco and Maggi, Fabrizio and Antinori, Andrea},
title = {Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28868}
}
EUVIMED